HEERMA PETER (Chief Commercial Officer) sold 4.9% of their position (7.21K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $302.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/16/2026ACC: 0001789617-26-000002
Officer· Chief Commercial Officer
Since Oct 2019
+6.79K
Net shares
Net buyer
$302.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
14K acquired · 7.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14K
Price / share
—
Trade value
—
% of position
10.6%
4/13/2026
131.82K→145.82K
Common Stock
Direct
Shares
−7.21K
Price / share
$41.93
Trade value
$302.52K
% of position
4.9%
4/14/2026
145.82K→138.61K
Total
Net shares
+6.79K
Net value
-$302.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/13/2026 | A · Award | +14K | — | — | 10.6% | 131.82K | 145.82K |
| Common Stock Direct | 4/14/2026 | S · Sale | −7.21K | $41.93 | $302.52K | 4.9% | 145.82K | 138.61K |
| Total | +6.79K | -$302.52K | ||||||
Derivative Transactions0
No derivative transactions reported